Evidence map›Paper›PMID 37947766›Full record

ArticleAntimicrobial agents and chemotherapy2023

Geographical emergence of sulfadoxine-pyrimethamine drug resistance-associated

Francis N Nkemngo, Lymen W Raissa, Daniel N Nguete, Cyrille Ndo, Jerome Fru-Cho, Flobert Njiokou, Samuel Wanji, Charles S Wondji

Open access · hybridAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Francis N NkemngoCentre for Research in Infectious Diseases (CRID), Yaoundé, Cameroon.ORCID 0000-0003-4292-8440
Lymen W RaissaCentre for Research in Infectious Diseases (CRID), Yaoundé, Cameroon.
Daniel N NgueteCentre for Research in Infectious Diseases (CRID), Yaoundé, Cameroon.
Cyrille NdoCentre for Research in Infectious Diseases (CRID), Yaoundé, Cameroon.
Jerome Fru-ChoDepartment of Microbiology and Parasitology, Faculty of Science, University of Buea, Buea, Cameroon.
Flobert NjiokouCentre for Research in Infectious Diseases (CRID), Yaoundé, Cameroon.
Samuel WanjiDepartment of Microbiology and Parasitology, Faculty of Science, University of Buea, Buea, Cameroon.
Charles S WondjiCentre for Research in Infectious Diseases (CRID), Yaoundé, Cameroon.ORCID 0000-0003-0791-3673
Ministry of Scientific Research and Innovation · CMUniversity of Buea · CMLiverpool School of Tropical Medicine · GBUniversity of Douala · CM

Funding

Wellcome Trust
6 · The paper itself

Abstract

Malaria molecular surveillance remains critical in detecting and tracking emerging parasite resistance to anti-malarial drugs. The current study employed molecular techniques to determine

Indexed as

AnophelesAntimalarialsMalariaMalaria, FalciparumAllelesAnimalsCameroonDrug CombinationsDrug ResistanceHumansPlasmodium falciparumPyrimethamineSulfadoxineTetrahydrofolate DehydrogenaseAntimalarialsDrug Combinationsfanasil, pyrimethamine drug combinationPyrimethamineSulfadoxineTetrahydrofolate DehydrogenaseAnopheles mosquitoesCameroondrug resistancehumansP. falciparumP. malariaesulfadoxine-pyrimethamine

Identifiers

PMID37947766
PMCPMC10720508
OpenAlexW4388565220

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.